Cardlytics (CDLX) Tops Q4 EPS by 28c, Beats on Revenue

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of $0.00, $0.28 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $55.17 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Dollar Tree (DLTR) falls 5.6% after Director filed notice to sell $133.1M worth of shares
• Barclays Reiterates Equalweight Rating on Tesla (TSLA)